Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$968,814
+$109,294 QoQ
Shares Held
3,850
-2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.21%
of 13F equity value
Holder Rank
#2,574
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Network Wealth Advisors LLC holds $2,004,784 across 12 Drug Manufacturers - General names. ABBV ranks #1 (48.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
3,850 | $968,814 | |
| 2 | NVO |
Novo Nordisk A S
|
4,942 | $236,919 | |
| 3 | JNJ |
Johnson & Johnson
|
898 | $228,065 | |
| 4 | LLY |
ELI LILLY & Co
|
143 | $171,518 | |
| 5 | PFE |
Pfizer Inc
|
6,438 | $155,027 | |
| 6 | MRK |
Merck & Co., Inc.
|
487 | $62,579 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
939 | $54,105 | |
| 8 | NVS |
Novartis AG
|
334 | $52,344 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $968,814 | 3,850 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $859,520 | 3,952 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $907,333 | 3,971 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $944,220 | 4,078 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $752,317 | 4,053 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $847,508 | 4,045 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $559,577 | 3,149 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $828,428 | 4,195 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $734,961 | 4,285 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $762,088 | 4,185 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $661,102 | 4,266 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||